TruTechnologies, makers of TruLab

Clinical trials don’t happen behind a desk — they happen at the point of care. Shouldn’t site teams have technology that moves with them instead of slowing them down? With TruTechnologies, sites capture data in real time — without the need for paper — ensuring better workflows, fewer errors, and instant sponsor oversight. #clinicaltrials #clinicalresearch

? Exciting News! ? We’re thrilled to announce that Collier Wright, VP of Solutions at TruTechnologies, has been named one of the 2025 Triangle Business Journal 40 Under 40 Leadership Awards winners! The 40 Under 40 awards recognize exceptional professionals under 40 who are making a significant impact on their organizations and communities. As TBJ President and Publisher Sougata Mukherjee put it: “These winners are full of entrepreneurial spirit and reflect the economic prowess of the community in which we live and work. The Triangle is a better place because of the efforts of these honorees.” Congratulations to Collier on this well-deserved recognition! ?? Read more about the 2025 class of 40 Under 40 winners: https://lnkd.in/eZgcX7Mt #Leadership #ClinicalTrials

20% of samples in clinical trials end up unusable. That's wasted time, wasted resources, and compromised data integrity. Why? Because tracking doesn’t start early enough. TruTechnologies changes that. By automatically capturing sample metadata at the point of collection, the TruLab app enables real-time protocol deviation detection to prevent errors before they impact your study. ?? Watch the video to see why it’s time for a new approach to sample tracking and protocol compliance. #clinicaltrials #clinicalresearch #protocolcompliance

Clinical pharmacology teams depend on high-quality data — but what happens when operational complexities, site burden, and protocol deviations get in the way? Join us for a live webinar on March 27 at 12 PM ET / 9 AM PT, featuring Brian Corrigan, Former Sr. VP, Translational Clinical Sciences at Pfizer, and Dave Bourdet, VP, Head of Clinical Pharmacology at Vividion Therapeutics, in a discussion on the biggest challenges facing #clinicalpharmacology today. Moderated by Peter Brown, President of TruTechnologies, this panel will explore sample timing errors, data inconsistencies, and the evolving role of PK/PD in decision-making. ?? Don’t miss this discussion — register now! https://lnkd.in/eKmYgNAT

?? Less than 5 months to go. ICH E6(R3) takes effect in the EU on July 23, 2025. Is your clinical trial oversight strategy ready? ?? Swipe through to see what’s changing.

Clinical pharmacology teams rely on high-quality data, but protocol deviations, site burden, and operational misalignment create real challenges. How can pharma teams navigate these complexities while maintaining both speed and data integrity? Join us on March 27 at 12 PM ET / 9 AM PT for a panel discussion featuring industry experts: ?? Brian Corrigan – Fmr. Sr. VP, Translational Clinical Sciences, Pfizer ?? Dave Bourdet – VP, Head of Clinical Pharmacology, Vividion ?? Peter Brown – President, TruTechnologies They’ll share real-world experiences and insights on bridging operational gaps, reducing data inconsistencies, and improving clinical pharmacology oversight. ?? Save your spot! https://lnkd.in/eKmYgNAT

In 2025, why are clinical trial sites still relying on handwritten notes and tube labels? The problem isn’t technology — it’s how it fits into site workflows. #clinicaltrials #clinicalresearch

In 2025, an estimated 154,270 people will be diagnosed with colorectal cancer. When caught early, it’s one of the most preventable cancers — but for later-stage cases, innovation in treatment is critical. Recent advances, like new KRAS-targeted therapies and blood-based screening tests, are changing the landscape for patients. With ongoing research, #clinicaltrials continue to push the boundaries of what’s possible in detection and treatment. Learn more about your personal screening recommendation at GetScreened.org. #ColorectalCancerAwarenessMonth

When a clinical team refused to engage with new technology, it wasn’t just skepticism — it was a lack of trust that the system could adapt to their needs. But when they saw it in action, everything changed. ?? The key? Technology that works the way sites do. In this clip from our recent webinar, Peter Brown and Andrea Bastek discuss what it really takes to drive adoption at clinical sites. #ClinicalTrials #ClinicalOperations #GoPaperless

Ditch the paper. Sites deserve tools that make protocol compliance easier and ensure samples reach testing labs without the hassle. #ClinicalTrials #GoPaperless